The Health Failure
Synthetic sweeteners
Aspartame and sucralose face severe health and clean-label backlash — a dead end for natural positioning.
Deep-Tech IP Company · DPIIT-Recognised Startup
A hard-tech sweetener platform fixing India’s metabolic-health crisis from the molecule up. We engineer the next generation of functional carbohydrate systems to deliver uncompromised sugar taste, structural utility and metabolic safety across industrial and retail food matrices.
02 / The Sugar Crisis
77Cr+
Indians carry a metabolic-health burden
Yet every sweetener on the market fails on health, gut tolerance or industrial processability — and manufacturers pay the price on the line.
The Health Failure
Aspartame and sucralose face severe health and clean-label backlash — a dead end for natural positioning.
The Gut Failure
Erythritol and other polyols cause bloating and gastrointestinal distress — the exact problem clinical patients cannot tolerate.
The Industrial Failure
The ideal zero-glycemic rare sugar — but fiercely hygroscopic. In tropical Indian humidity it absorbs moisture and cakes into sticky blocks that paralyse high-speed FMCG lines.
03 / Our Deep-Tech Solution
A 100% natural, polyol-free, co-crystallized matrix. We do not dry-blend; we engineer. Zurose uses a proprietary top-spray fluid-bed micro-atomization and co-crystallization process.
Freely flowing D-Allulose seed crystals are fluidized in a dehumidified chamber.
An ultra-low dose of Monk Fruit extract is micro-atomized from the top spray and flash-welded into the crystal’s micro-crevices.
A natural Acacia arabica hydrocolloid glaze seals each particle — solving the hygroscopic trap.
Mimics the Maillard browning, caramelization and physical bulk of real sugar.
Stays free-flowing and resists clumping even in extreme tropical humidity.
Content uniformity of CV < 2% means identical sweetness in every crystal — unlike dry blends that separate.
04 / Product Pipeline
05 / Intellectual Property & Asset-Light Model
80% · The Patent
Our structural core-shell co-crystal architecture is protected under Indian Provisional Patent Application No. 202611078064.
20% · The Trade Secret
The specific thermodynamic scale-up parameters — including tight thermal-mass windows and dew-point micro-environments — are retained as closely guarded internal trade secrets, protecting the venture against multinational commodity giants.
Zurose Technologies Private Limited operates strictly as a deep-tech Intellectual Property holding platform.
₹0
Manufacturing is executed through elite, FSSAI-compliant Contract Development and Manufacturing Organizations (CDMOs).
IP
Distribution and initial pilot sales are exclusively licensed to Zeus Distributors Private Limited (ZDPL), keeping R&D capital protected within the IP entity.
>60%
Healthy unit economics fund market expansion without tying capital to bricks and mortar.
06 / Investor Relations & Government Alignment
Zurose Technologies is an officially recognised Startup under DPIIT (Certificate No. DIPP291523). We are executing a roadmap that leverages non-dilutive government support alongside private capital.
DPIIT · Startup India
Certificate No. DIPP291523
SISFS
Supporting registered clinical validation.
iStart Rajasthan
Including women-entrepreneur incentives.
SIPP
Supporting our global PCT patent portfolio.
Seed Stage Current
₹1 Cr – ₹2.44 Cr seed round
Finalise CDMO pilot validations, execute registered clinical CGM trials, and launch our clinic-first go-to-market through diabetologists and endocrinologists.
Series A · Year 2
₹12 Cr target valuation
Backed by clinical prescriptions (5,000+ doctor prescription leads) and a D2C repeat-purchase rate above 40%.
Strategic · Year 3
₹300 Cr+ acquisition target
Scaling through bulk B2B licensing and retail leadership toward a strategic exit to global sweetener and pharma majors.
Request the investor deck, data-room access or B2B licensing details.
Forward-looking figures are targets, not guarantees. This website is for information only and does not constitute an offer, invitation or solicitation to subscribe to securities of Zurose Technologies Private Limited.
07 / The Founders
Co-Founder & Promoter
Drives the clinical, nutritional and metabolic strategy, ensuring Zurose aligns strictly with medical nutrition therapy standards. A woman entrepreneur leading the charge for a healthier India.
Founder & Director
Spearheads the corporate architecture, intellectual-property defence strategy, CDMO scale-up operations and venture-capital roadmap.
nimit.kasliwal@zurose.inContact
Seed round, government programmes, B2B licensing or clinical collaboration — we’d like to hear from you.